Highlights include: • Once-weekly vs twice weekly carfilzomib for newly diagnosed MM • Negative trials for pembrolizumab in treatment naive and...
Myeloma NZ
Drug Previously Thought to Treat Alzheimer Shows Potential in Multiple Myeloma
Results from a new study at Hutchinson Cancer Research Cancer in Seattle suggests that chimeric antigen receptor (CAR) T-cell therapy can be further...
Cancer Control Agency open, Prime Minister hails Blair Vining’s ‘tireless advocacy’
The Prime Minister has acknowledged Blair Vining's "tireless advocacy" as the new independent Cancer Control Agency was formally opened on Tuesday....
Major developments in multiple myeloma to be presented at ASH
Starting Saturday, December 7, HemOnc Today will be onsite in Orlando at the ASH Annual Meeting and Exposition, bringing the latest in important,...
Myeloma Medicines Applications: The status of medicines applications for myeloma currently with Pharmac
A summary of events and the status of medicines applications for myeloma currently with Pharmac  Tania Crosbie Special Projects Manager, Myeloma...
Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis
The objective of the study was to assess racial disparities in the treatment and outcomes among white, African American, and Hispanic patients with...
Myeloma New Zealand Christmas Function
Ken Romeril, CEO Myeloma New Zealand Charitable Trust invites you to the Myeloma New Zealand Christmas Function. Wednesday 11 December, 5.00pm at...
Petition for Patient Voice Aotearoa: Reform Pharmac and double the Pharmac budget
There are issues involving Pharmac and how they fund medicines - Pharmac does not adopt international guidelines; it does not set a timeframe by...
FDA Approves Daratumumab-Based Quadruplet Regimen for Transplant-Eligible Myeloma
The U.S. Food and Drug Administration (FDA) approved the quadruplet regimen consisting of daratumumab, bortezomib, thalidomide, and dexamethasone to...
Submission on the draft Cancer Action Plan 2019-2029
Myeloma New Zealand submitted an online response to the plan on behalf of myeloma patients, pointing in particular to the need for full inclusion of...
Prophylactic antibiotics could benefit patients with newly diagnosed myeloma
Newly diagnosed patients with myeloma who are about to start treatment may benefit from a fixed course of prophylactic antibiotics to prevent...
Funding Medicines in New Zealand: Revision of the Medicines waiting list to 30 June 2019
An update of the Medicines Waiting List report has just been released. The Medicines Waiting List shows how long patients have been waiting for...